Medicine and Dentistry
Krukenberg Tumor
100%
Disease
60%
Ovarian Cancer
58%
Endometrial Cancer
56%
Neoplasm
54%
Neoadjuvant Chemotherapy
53%
Elderly Patient
49%
Laparotomy
48%
Hysterectomy
38%
Endometrium Carcinoma
35%
Vulva
35%
Overall Survival
32%
Ascites
26%
Progression Free Survival
25%
Vaginal Ultrasonography
23%
Pelvis
23%
Surgery
23%
Lymph Node
22%
Symptom
22%
Wound
22%
Disease Course
21%
Uterine Cervix Carcinoma
19%
Fine-Needle Aspiration
17%
Genital Wart
17%
Oncology
17%
Receptor Gene
17%
Burkitt's Lymphoma
17%
Edema
17%
Peritoneal Fibrosis
17%
Chemoradiotherapy
17%
Anticonvulsant Therapy
17%
Adjuvant Chemoradiotherapy
17%
Androgen Receptor
17%
Bacterial Vaginosis
17%
Conservative Treatment
17%
Robot-Assisted Surgery
17%
Fluorouracil
17%
CAG Repeat
17%
Postoperative Period
17%
Malignant Ascites
17%
Endometrioid Carcinoma
17%
Prognostic Factor
17%
Granular Cell Tumor
17%
Laparoscopy
17%
Squamous Cell Carcinoma
17%
Thecoma
17%
Folinic Acid
17%
Carbon Dioxide
17%
Neutrophil
17%
Lymphadenopathy
17%
Keyphrases
Endometrial Cancer
56%
Ovarian Carcinoma
55%
Elderly Patients
53%
Neoadjuvant Chemotherapy
53%
Ovarian Cancer
49%
Advanced Stage
41%
Tumor
38%
BRCA mutation Carriers
35%
Advanced Ovarian Carcinoma
35%
Simple Hysterectomy
35%
Sentinel Lymph Node Mapping
35%
Laparotomy
30%
Stage IIIC
28%
Disease-free Interval
28%
Overall Survival
27%
Chemotherapy
26%
Sentinel Lymph Node
25%
Blue Dye
23%
Surgical Intervention
23%
Progression-free Survival
21%
Granular Cell Tumor
21%
Clinical Course
21%
Ascites
21%
Salpingo-oophorectomy
21%
Robotic Surgery
20%
Cervical Carcinoma
20%
Interval Cytoreduction
19%
Residual Disease
19%
Between-group
19%
Young Patients
19%
Inclusion Criteria
18%
Hysterectomy
18%
Oncology Patients
17%
Israeli Women
17%
Yogurt
17%
Gynecologic Oncology
17%
Condyloma Acuminatum
17%
Cystic Lesion
17%
Vulvar Squamous Cell Carcinoma
17%
Stage IB2
17%
Sclerosing Mesenteritis
17%
Complete Responders
17%
Expression Pattern
17%
Heavily Pretreated
17%
Endometrial Carcinoma
17%
Chemoradiation
17%
Locally Advanced
17%
Newly Diagnosed
17%
Advanced Squamous Cell Carcinoma
17%
Non-specific Binding
17%